Understanding and mitigating cancer-related financial toxicity in China: challenges and recommendations
Open Access
- 17 June 2025
- journal article
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 60
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (72004034)
- China Medical Board Inc (20-371)
This publication has 21 references indexed in Scilit:
- Trajectories and predictors of financial toxicity in breast cancer patients: A multicenter longitudinal study in ChinaThe Breast, 2025
- The development and preliminary evaluation of a financial navigation program among patients with breast cancer in ChinaAsia-Pacific Journal of Oncology Nursing, 2025
- Post‐Treatment Cancer Survivors' Experience of Social Reintegration: A Systematic Review and Meta‐SynthesisPsycho-Oncology, 2024
- Financial toxicity and its risk factors among patients with cancer in China: A nationwide multisite studyAsia-Pacific Journal of Oncology Nursing, 2024
- Interventions for financial toxicity among cancer survivors: A scoping reviewCritical Reviews in Oncology/Hematology, 2023
- The Pathway of China’s Integrated Delivery System: Based on the Analysis of the Medical Consortium PoliciesCurrent Medical Science, 2022
- A systematic review of financial toxicity among cancer patients in ChinaAsia-Pacific Journal of Oncology Nursing, 2022
- Financial toxicity and employment status in cancer survivors. A systematic literature reviewSupportive Care in Cancer, 2020
- Relationships Between Financial Toxicity and Symptom Burden in Cancer Survivors: A Systematic ReviewJournal of Pain and Symptom Management, 2019
- The internet hospital: an emerging innovation in ChinaThe Lancet Global Health, 2015